The aim of the present study was to establish an animal model of prostatic hyperplasia to
explore the mechanisms of this disease. Sulpiride, a specific type 2 dopamine receptor …

WS® 1541, a phytopharmaceutical product based on a combination of extracts from fruits of
Sabal serrulata (WS® 1473) and roots from Urtica dioica (WS® 1031), is used to treat …

Prolactin (PRL) is implicated in prostate growth and in the development and regulation of
benign prostatic hypertrophy (BPH) and prostate cancer (PCa). PRL may exert its effects on …

Androgen and estrogen play an important role in the pathogenesis of benign prostatic
hyperplasia (BPH). Estrogen exerts its action through two distinct estrogen receptors (ERs) …

The efficacy of a novel Prunus domestica bark extract (Sitoprin, CR002) was investigated on
testosterone propionate (TP)-induced benign prostatic hyperplasia (BPH) in male Wistar …

Benign prostatic hyperplasia (BPH) is considered a normal part of the aging process in men,
and is characterized by an imbalance between cell proliferation and apoptosis. Our study …

This study proposed to investigate further the role of oestrogens during pubertal growth of rat
ventral prostate, by analysing the effect of anti‐oestrogen fulvestrant (ICI 182,780) on the …

Resveratrol can inhibit cell proliferation and metastasis and induce apoptosis. However, the
mechanisms of action through which resveratrol inhibits the abnormal proliferation of …

The current study aimed to investigate the potential role of the anti-inflammatory effects of
silymarin (SIL) in inhibiting experimentally induced benign prostatic hyperplasia (BPH) in …

Benign prostatic hyperplasia (BPH) is characterized by non-malignant enlargement of
prostate cells causing many lower urinary tract symptoms. BPH pathogenesis includes …